Analysis of formal purchasing channels and patient purchasing guide for ruxolitinib cream (Opzelura)

Ruxolitinib cream (Opzelura) is a topical JAK inhibitor used to treat vitiligo and specific skin diseases. It has not yet received marketing approval in China. Therefore, domestic patients cannot purchase the drug directly through regular hospitals or pharmacies, which also means that obtaining Opzelura in China requires overseas channels, and special attention needs to be paid to the legality and safety of the drug.

Overseas channels are currently the main way for patients to obtain Opzelura. Original medicines are sold in the United States, Europe and other regions at relatively high prices. Generally, a single ointment can cost more than 10,000 yuan. When choosing overseas purchase channels, patients should give priority to international pharmacies with formal drug qualifications and legal export channels, and avoid purchasing through informal platforms to prevent the purchase of counterfeit drugs or products of substandard quality.

In order to reduce the financial burden, some patients will choose generic drugs from Bangladesh and other countries. The price of such generic drugs is about a few hundred yuan, and the drug ingredients are highly similar to the original drugs, and the clinical effects can usually reach the therapeutic level of the original drugs. However, it is still necessary to pay attention to the legality of drug sources, quality testing, and transportation and storage conditions when using them to ensure that the drugs are not contaminated or deteriorated during use.

As for the purchasing guide, patients should consult a professional dermatologist before obtaining Opzelura to clarify the dosage, course of treatment and usage. At the same time, it is recommended to place orders through regular overseas pharmacy platforms or international medical service institutions, and pay attention to the temperature and storage requirements during transportation. After receiving the medicine, patients should strictly follow the doctor's instructions and follow up with the doctor regularly to observe the efficacy and monitor possible adverse reactions.

Reference materials:https://www.drugs.com/